SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following geographical segments: Major Domestic Appliances (MDA) North America, Major Domestic Appliances (MDA) Latin America, Small Domestic Appliances (SDA) Global, and Others. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpools weak quarterly results, sharply reduced full-year outlook and suspension of its dividend have intensified selling and concerns about its finances; the company cited recession-level appliance demand and weaker consumer confidence. Traders debate whether macroeconomic pressures are chiefly to blame or whether years of debt and management problems are driving the decline, with some viewing the selloff as a buying opportunity and others fearing further distress.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is drawing attention after a cybersecurity-sector rally tied to headlines about AI-discovered vulnerabilities and a critical PHP flaw, which traders say could heighten demand for security products. Some see the move as evidence of strong sector momentum, while others question whether the rally is justified given CRWDs lofty valuation.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

ARKK is drawing attention for a tentative rebound and attempts to break out of a prolonged, volatile base, with bullish traders pointing to improving momentum and renewed interest in growth stocks. Others remain skeptical, citing the funds past underperformance and Cathie Woods portfolio decisions.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

ESMO updates on RASONQUE and RAS-targeted combinations are driving discussion, including reported survival benefits across patient subgroups and promising pancreatic-cancer data from Tangos combination with daraxonrasib. Traders are debating whether delays among rival programs could extend Revolution Medicines lead, while weighing the competitive landscape and how the clinical findings translate into durable benefit.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JDs earnings have sparked debate after shares sold off despite improving profitability and cash flow: bulls view the reaction as excessive and cite the companys cash, buybacks and low valuation, while bears focus on declining revenue and weak Chinese consumer demand. The discussion also reflects persistent caution toward Chinese equities and uncertainty over whether JD can turn better margins into renewed growth.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Toshibas plans to expand hard-drive capacity have pressured Seagate on fears that added supply could erode HDD pricing power, with reports of a SeagateToshiba contest for TDKs magnetic-head business adding uncertainty. Traders are split between seeing the selloff as an overreaction given strong AI data-center storage demand and a long supply ramp, and viewing increased competition as a threat to the scarcity-driven rally.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

A reopened Space Force SCAR procurement process and related securities-suit allegations over whether AeroVironment disclosed competition risks have weighed on shares; the claims remain allegations. Traders are debating whether the sharp selloff has created a base or could extend, while bulls point to defense contracts, backlog and counter-drone demand as support for a recovery case.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is drawing attention amid a volatile crypto-market pullback, with traders focused on whether it can hold technical support after selloffs and leveraged-position liquidations. Sentiment is split between calls for further downside and dip buyers anticipating a reversal or short squeeze.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Attention centers on reports that Papa Johns largest U.S. franchisee has joined Irth Capitals effort to take the company private. No deal is confirmed, and traders are debating whether negotiations will advance or the board will reject or delay a sale, against a backdrop of weak sales and a sharp share-price decline.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

VOO is drawing attention amid a broader market pullback, with traders debating whether weakness tied to inflation, elevated yields and geopolitical oil risks could deepen or prove temporary. Bearish crash warnings contrast with dip-buying and long-term investors who view index declines as accumulation opportunities.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ABVX Stock Clocks Best Day In 11 Months On Analyst Upgrades After Fresh Data Eases Drug Safety Concerns 

Equity

Wedbush, BTIG and Jefferies weighed in on ABVX on Tuesday after the company unveiled updated safety and efficacy data from an obefazimod study. 


ABVX Stock Rockets 28% After Abivax Eases Drug Safety Concerns With Fresh Clinical Data

Abivax said the findings strengthen the overall case for obefazimod and reinforce its favorable benefit-risk profile.


ABVX Stock Clocks Worst Day Ever On Malignancy Signal For Drug: ‘Pharma Bro’ Says ‘GLPs Are Doing Fine’ After Similar Fears  

Shares of ABVX closed down 44% on Tuesday, clocking its worst day ever, on reports of a number of non-melanoma skin cancers and other malignancies observed in its ulcerative colitis trial. 


ABVX Tanks 30% After-Hours Despite 51% Remission In Ulcerative Colitis Trial — Rare Cancer Concerns Hit Sentiment

The company dismissed the cancers observed in the trial as rare, occurring primarily in older patients, and largely unrelated to treatment. 


Goldman Sachs ETF Trust - Goldman Sachs Hedge IND VIP ETF

Neutral Sentiment

<ul class="summary-bullets"><li>BTIG raised its price target on Abivax to $175 from $150 and maintained a Buy rating.</li><li>Wedbush said that it remains concerned about how the FDA will view cancer risk and the potential for a Black Box warning.</li><li>Abivax also announced on Tuesday the launch of an underwritten public offering of around $600 million in American Depositary Shares.</li></ul><p>Shares of Abivax (ABVX) clocked their best day in about 11 months on Tuesday on the heels of multiple price target revisions and updated safety and efficacy data from a study that addressed prior investor worries about cancer risk tied to its ulcerative colitis candidate, obefazimod.</p><p>ABVX stock closed 39% higher and slipped marginally by 0.15% after-hours, at the time of writing, after the company announced a $600-million public offering.</p><h2 class="st-heading-2">Trial Data</h2><p>Abivax <a href="https://stocktwits.com/news-articles/markets/equity/abvx-stock-rockets-after-abivax-eases-drug-safety-concerns-with-fresh-clinical-data/cZ19pPuR7L8">released</a> the updated study data after-hours on Monday. The data showed malignancy rates, including non-melanoma skin cancers, remained consistent with background rates in ulcerative colitis patients. Four NMSC cases were reported in Part 2 of the trial—two per dose arm—mostly in patients with pre-existing risk factors, while two additional non-NMSC malignancies in the 50 mg group were deemed unrelated to the drug.</p><p>Abivax said the data reinforce obefazimod’s favorable benefit-risk profile. More than one-third of patients in the higher-dose group achieved clinical remission and mucosal healing at week 44. The company plans to submit a U.S. FDA new drug application in the fourth quarter.</p><h2 class="st-heading-2">Wall Street Weighs In</h2><p>BTIG raised its price target on Abivax to $175 from $150 and maintained a Buy rating. The analyst said the latest update provided additional safety data confirming a sufficiently clean safety profile for obefazimod. BTIG’s new price target represents a potential upside of about 31% from the stock’s closing price on Tuesday.</p><p>Wedbush analyst David Nierengarten raised the firm’s price target to $110 from $90 but kept a Neutral rating. While the pooled safety data appeared in line with background malignancy rates in ulcerative colitis, Wedbush remains concerned about how the FDA will view cancer risk and the potential for a Black Box warning. Nierengarten’s new price target assumed a potential downside of about 17% from the stock’s closing price.</p><p>Jefferies upgraded Abivax to Buy from Hold and lifted its price target to $158 from $108, representing a potential upside of nearly 19% from the stock’s last close. The firm said the Part 2 update “appropriately addresses the key overhang facing the stock” and that management did a good job addressing investor concerns with the presentation of the safety data. Jefferies also noted that the efficacy profile continues to strengthen with additional data.</p><h2 class="st-heading-2">Abivax Launches $600-Million Public Offering</h2><p>Separately, Abivax announced on Tuesday the launch of an underwritten public offering of around $600 million in American Depositary Shares. The company intends to use the net proceeds for U.S. commercialization expenses of obefazimod, clinical development in ulcerative colitis and Crohn’s disease, and general corporate purposes.</p><h2 class="st-heading-2">How Did ABVX Retail Traders React?</h2><p>On Stocktwits, retail sentiment around ABVX stayed within the ‘bullish’ territory over the past 24 hours, while message volume jumped from ‘normal’ to ‘high’ levels.</p><p>A Stocktwits user opined that the capital raise is to convince interested partners that the company can also move forward solo.</p><p><stembedurl>https://www.stocktwits.com/Miles223/message/657970692</stembedurl></p><p>Another user echoed the sentiment, positioning the capital raise as proof that the company received “lowball M&amp;A offers.”</p><p><stembedurl>https://www.stocktwits.com/p3akyblinder/message/657971234</stembedurl></p><p>A third user voiced hopes for an imminent near-term buyout for the company.</p><p><stembedurl>https://www.stocktwits.com/MZ2X/message/657969299</stembedurl></p><p><a href="https://stocktwits.com/symbol/ABVX">ABVX stock</a> has traded nearly flat year-to-date.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/uncy-stock-clocks-worst-day-in-year-analysts-keep-buy-ratings-despite-5-12-month-delay-in-drug-approval/cZ1QMSoR70o">UNCY Stock Clocks Worst Day In A Year — Analysts Keep Buy Ratings Despite ‘5-12 Month Delay’ In Drug Approval</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, the Abivax logo is seen displayed on a smartphone screen

Wedbush, BTIG and Jefferies weighed in on ABVX on Tuesday after the company unveiled updated safety and efficacy data from an obefazimod study. 

Abivax - ADR

iShares Biotechnology ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

GVIP Goldman Sachs ETF Trust - Goldman Sachs Hedge IND VIP ETF

Fundamentals

Latest GVIP News